echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The amount of financing topped the list!

    The amount of financing topped the list!

    • Last Update: 2021-08-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On August 4, Herui Gene officially announced the completion of the B1 round of financing


    Herui Gene was established in August 2017.


    According to statistics, in 2020, a total of 16 companies with a clear early screening business layout completed 17 financings, with a cumulative financing amount of approximately 6.


    Herui Gene's PreCar liver cancer early screening project with a total investment of more than 200 million yuan is the first and only prospective cohort research project of ultra-large-scale liver cancer early screening based on NGS technology in China.


    On June 22, 2021, the country’s first "Expert Consensus on Early Liver Cancer Screening Strategies in China" was officially released.


    In addition, the company’s liver cancer early screening product "Laisining" relies on the national 13th Five-Year Plan of major scientific research projects.


    In response to the success of this financing, Herui Gene CEO Zhou Jun said: "Herui Gene will continue to adhere to the mission of'achieve early diagnosis and treatment of all tumors, and obtain precise treatment for all patients'.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.